Skip to NavigationSkip to content

News

All atypical anti-psychotic drugs are to carry warnings on their US labels about potentially fatal hyperglycaemia side-effects and increased risk of...
The first components of the new GP contract are to be implemented following agreement on doctorspay and improvements to premises.
Job cuts at Merck
Apotex has launched the first generic version of GlaxoSmithKline blockbuster antidepressant Paxil (paroxetine) in the US, several months earlier than...
A new rival to blockbuster Cox-II inhibitor drugs from Pfizer and Merck Sharp & Dohme has been approved in the UK.
A special World Health Organisation team has praised the groundbreaking work of NICE but has called for its dealing with industry to be more...
Restructure unveiled as Pfizer takes merger hit
A new private European pharma company has been launched that will exploit products made available through the spate of industry mergers, acquisitions...
AstraZeneca has become the second major pharma company to limit sales of drugs to Canada in a bid to curb parallel imports across the border into the...
Pharmaceutical industry 'disease awareness campaigns' aimed at UK consumers are to be governed by new guidelines to formalise the practice and clear...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches